Boris Azaïs is currently Director, Public Policy Europe for MSD (a subsidiary of Merck & Co., Inc., Kenilworth, N.J., USA ).

In his capacity, Boris Azaïs engages with European institutions and governments to promote a policy framework that supports pharmaceutical innovation for European patients. His core interest is at the crossroads of research, health and industrial policy, each playing a critical role in ensuring that science is turned into novel medicines that can help patients live better and healthier lives. Boris is currently chairing EFPIA’s Healthcare Systems Working Group and is also involved in advocacy efforts with stakeholders and patient groups related to various therapeutic areas.

Boris Azaïs joined MSD in 1998, as Legal Director for Middle-East & Africa, after a multi-year practice as a corporate lawyer for the firm Cleary, Gottlieb, Steen & Hamilton in Paris.